Welcome to our media centre, here you will find a range of resources including our press releases, news updates and information related to the conferences and events we attend each year.
These press releases and news updates are intended for media and investors only.
UPCOMING CONGRESS
26 - 31 July, 2026
We are excited to attend the 26th International AIDS Conference in Rio de Janeiro, Brazil. AIDS is the world’s largest conference on HIV and AIDS, bringing together people living with HIV, researchers, policy makers, healthcare professionals, funders, media and communities.
29 JULY 2026
Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026
29 JULY 2026
New European, community co-created survey reveals strong interest in long-acting HIV treatment options but reported in-clinic conversations lag behind
27 JULY 2026
ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV
21 JULY 2026
ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026
22 JUNE 2026
ViiV Healthcare advances paediatric HIV regulatory submissions with FDA Priority Review for Tivicay PD and EMA validation of marketing application for Tivicay
11 MAY 2026
ViiV Healthcare aims to close treatment gaps for children living with HIV with paediatric Dovato marketing applications to the EMA and FDA
30 APRIL 2026
ViiV Healthcare ranked #1 by patient groups for 13th successive year in PatientView’s ‘Corporate Reputation of Pharma – from the Patient Perspective 2025 - 2026’ survey
Media contacts
Media contact details for our global headquarters and USA. For press contacts in our local operating companies please visit our country websites.
If you have a media query please contact us
Global Press Office
Kate Senter
Head of Global Communications ViiV Healthcare
Tel: +44 7796 707446
NP-GBL-HVX-COCO-220039 | July 2026
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
